RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis

Quazi T. H. Shubhra

doi:10.1186/s40779-023-00480-w

Your Location：

Home >

Browse articles >

RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis

COMMENTARY | Updated：2025-12-13

- RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis
- RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis
- MMR 2024年11卷第2期页码：311-312
- Affiliations：
  
  1.Institute of Chemistry, University of Silesia in Katowice, 41-500 Chorzów, Poland
  2.Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
- Author bio：
  
  *tanminul-haque-shubra.quazi@us.edu.pl; shubhro.du@gmail.com
- Funds：
- DOI：10.1186/s40779-023-00480-w
  中图分类号：
- 纸质出版：2024-04
- Accepted：
Scan QR Code
RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis[J]. MMR, 2024,11(2):311-312.

Cite this article as: Shubhra QTH. RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis. Mil Med Res. 2023;10(1):42.
RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis[J]. MMR, 2024,11(2):311-312. DOI： 10.1186/s40779-023-00480-w.

Cite this article as: Shubhra QTH. RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis. Mil Med Res. 2023;10(1):42. DOI： 10.1186/s40779-023-00480-w.

摘要

Abstract

关键词

Keywords

references

Li YQ , Sun FZ , Li CX , Mo HN , Zhou YT , Lv D , et al . RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer . Mil Med Res . 2023 ; 10 ( 1 ): 34 .

Guo K , Xiao N , Liu Y , Wang Z , Tóth J , Gyenis J , et al . Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: opportunities and challenges . Nano Mater Sci . 2022 ; 4 ( 4 ): 295 – 321 .

Sirhan Z , Thyagarajan A , Sahu RP . The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer . Mil Med Res . 2022 ; 9 ( 1 ): 39 .

Ernst MC , Sinal CJ . Chemerin: at the crossroads of inflammation and obesity . Trends Endocrinol Metab . 2010 ; 21 ( 11 ): 660 – 7 .

Rennier K , Shin WJ , Krug E , Virdi G , Pachynski RK . Chemerin reactivates PTEN and suppresses PD-L1 in tumor cells via modulation of a novel CMKLR1-mediated signaling cascade . Clin Cancer Res . 2020 ; 26 ( 18 ): 5019 – 35 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Unresolved questions in the application of artificial intelligence virtual cells for cancer research

Impact of targeting the platelet-activating factor and its receptor in cancer treatment

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease

Association between periodontal disease and systemic diseases: a cross-sectional analysis of current evidence